Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date

PHASE4CompletedINTERVENTIONAL
Enrollment

659

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

December 31, 2009

Conditions
Smoking Cessation
Interventions
DRUG

placebo

placebo tablet taken orally twice daily for 12 weeks

DRUG

varenicline

varenicline tablets, 1 mg taken orally twice daily for 12 weeks

Trial Locations (33)

333

Pfizer Investigational Site, Gwei Shan Township, Taoyuan County

813

Pfizer Investigational Site, Kaohsiung City

1525

Pfizer Investigational Site, Budapest

4012

Pfizer Investigational Site, Debrecen

10787

Pfizer Investigational Site, Berlin

13760

Pfizer Investigational Site, Endwell

14033

Pfizer Investigational Site, Caen

15017

Pfizer Investigational Site, Bridgeville

19146

Pfizer Investigational Site, Philadelphia

37075

Pfizer Investigational Site, Göttingen

37203

Pfizer Investigational Site, Nashville

40509

Pfizer Investigational Site, Lexington

56124

Pfizer Investigational Site, Pisa

64460

Pfizer Investigational Site, Monterrey

66212

Pfizer Investigational Site, Overland Park

77030

Pfizer Investigational Site, Houston

85340

Pfizer Investigational Site, Litchfield Park

90095

Pfizer Investigational Site, Los Angeles

92705

Pfizer Investigational Site, Santa Ana

100020

Pfizer Investigational Site, Beijing

110016

Pfizer Investigational Site, Shenyang

510120

Pfizer Investigational Site, Guangzhou

01757

Pfizer Investigational Site, Milford

68116-2004

Pfizer Investigational Site, Omaha

C1405BCH

Pfizer Investigational Site, Buenos Aires

09060-650

Pfizer Investigational Site, Santo André

T1Y 6J4

Pfizer Investigational Site, Calgary

G1V 4M6

Pfizer Investigational Site, Québec

656 91

Pfizer Investigational Site, Brno

120 00

Pfizer Investigational Site, Prague

110-744

Pfizer Investigational Site, Seoul

135-710

Pfizer Investigational Site, Seoul

SW18 4DD

Pfizer Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00691483 - Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date | Biotech Hunter | Biotech Hunter